Paxlovid does not prevent COVID-19, new trial data show … Black and white patients have had similar risk of MS for decades, study finds … Parkinson’s drug hopeful found safe in early clinical trial...
‘A long time coming’: LTC infection preventionists get new certification option
By
Alicia Lasek (f3)
Apr 27, 2022
A new opportunity to receive industry-specific IPC board certification is a much-needed chance for LTC workers to build and show their niche expertise, experts say.
CDC: Turn to Paxlovid to treat COVID-19, not steroids or antibiotics
By
Alicia Lasek (f3)
Apr 26, 2022
The agency is urging clinicians to consider the now readily available, recommended therapies such as Paxlovid as first-line COVID-19 treatments.
Clinical briefs for Friday, April 22
By
Alicia Lasek (f3)
Apr 22, 2022
New data: AstraZeneca’s COVID-19 antibody Evusheld confers 83% protection at six months … Simple test in certain pneumonia patients could help cut broad-spectrum antibiotics use … Faster onset of...
Seniors on common maintenance drugs face fewer COVID-19 risks, NIH study finds
By
Alicia Lasek
Apr 20, 2022
Drugs used regularly in the long-term care population may help prevent SARS-CoV-2 infection and poor COVID-19 outcomes, investigators say.
SNF physicians’ unique skill set requires more definition and support, industry docs say
By
Alicia Lasek
Apr 15, 2022
Insights into these doctors’ contributions and constraints are highlighted in interviews with medical directors and attending physicians.
Clinical briefs for Tuesday, April 12
By
Alicia Lasek
Apr 12, 2022
NIH: Certain arthritis drugs lower incidence of Alzheimer’s in heart patients … Undercounting may hide new COVID-19 surge; whether that’s a problem depends on whom you ask … Collaboration between...
U.S. to test vaccine combos for future anti-variant strategy, Fauci says
By
Alicia Lasek
Apr 01, 2022
The NIH is launching a phase 2 clinical trial to help determine which vaccine combos can provide a broader immune response in adults who have already had a series of COVID-19 vaccinations.
Clinical briefs for Wednesday, March 30
By
Alicia Lasek
Mar 30, 2022
Senators want answers on Medicaid recipients’ low vaccination rates … FDA approves diabetes drug Ozempic (semaglutide) in 2 mg dose … COVID-19 infection plus flu a dangerous combination: study …...
Driven by pandemic lessons, CDC advisers mull endorsing high-dose flu vaccines for seniors
By
Alicia Lasek
Mar 15, 2022
A decision to recommend high-dose influenza shots over standard-dose vaccines would be a welcome change, long-term care stakeholders say.